This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Welsh, K. J.
Right arrow Articles by McGowan, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Welsh, K. J.
Right arrow Articles by McGowan, J. E., Jr.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, March 2005, p. 1242-1244, Vol. 49, No. 3
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.3.1242-1244.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Experimental Prediction of the Evolution of Ceftazidime Resistance in the CTX-M-2 Extended-Spectrum Beta-Lactamase

Kerry J. Welsh,1 Miriam Barlow,1* Fred C. Tenover,2 James W. Biddle,2 J. Kamile Rasheed,2 Leigh Ann Clark,1 and John E. McGowan Jr.1

Department of Epidemiology, Rollins School of Public Health, Emory University,1 Division of Healthcare Quality Promotion, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia2

Received 30 June 2004/ Returned for modification 26 September 2004/ Accepted 7 November 2004

We applied in vitro evolution to an Escherichia coli strain containing blaCTX-M-2 and obtained 10 independent mutant blaCTX-M-2 alleles that confer elevated resistance to ceftazidime (MIC ≥ 32 µg/ml) but lost the ability to confer resistance to cefepime. All alleles had a Pro-to-Ser substitution at position 167.

* Corresponding author. Mailing address: Department of Epidemiology, Emory University, 1518 Clifton Rd., Rm. L-21, Atlanta, GA 30322. Phone: (404) 727-3042. Fax: (404) 727-8737. E-mail: mbarlow{at}sph.emory.edu.

Antimicrobial Agents and Chemotherapy, March 2005, p. 1242-1244, Vol. 49, No. 3
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.3.1242-1244.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Girlich, D., Poirel, L., Nordmann, P. (2009). CTX-M Expression and Selection of Ertapenem Resistance in Klebsiella pneumoniae and Escherichia coli. Antimicrob. Agents Chemother. 53: 832-834 [Abstract] [Full Text]  
  • Novais, A., Canton, R., Coque, T. M., Moya, A., Baquero, F., Galan, J. C. (2008). Mutational Events in Cefotaximase Extended-Spectrum {beta}-Lactamases of the CTX-M-1 Cluster Involved in Ceftazidime Resistance. Antimicrob. Agents Chemother. 52: 2377-2382 [Abstract] [Full Text]  
  • Stepanova, M. N., Pimkin, M., Nikulin, A. A., Kozyreva, V. K., Agapova, E. D., Edelstein, M. V. (2008). Convergent In Vivo and In Vitro Selection of Ceftazidime Resistance Mutations at Position 167 of CTX-M-3 {beta}-Lactamase in Hypermutable Escherichia coli Strains. Antimicrob. Agents Chemother. 52: 1297-1301 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»